About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT06614478

Frailty, Hip Fractures and Inflammatory Biomarkers

We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.

Lead sponsor: University of Thessaly•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Eleni Arnaoutoglou, Professor

CONTACT

+302413502952 earnaout@gmail.com

Maria Ntalouka, MD, PhD, Mac

CONTACT

Sponsors

Lead Sponsor

University of Thessaly

Frailty (F) is a prevalent syndrome among elderly patient with hip fractures (HF) and has been linked to poor prognosis. Inflammatory biomarkers have been used as prognostic indexes in patients with HF. We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.

Age

65 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•age \&gt;65 years, ASA PS I-III, non- institutionalized, able to communicate patients

Exclusion Criteria

•Patients with severe cognitive dysfunction, those treated conservatively, those with pathological fractures and patients who refused to participate

Related studies

Health Ahead Comparative Effectiveness Study

NCT07669168 · Health Services Accessibility, Rural Health, and more

Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation

NCT07441382 · Atrial Fibrillation (AF), Stroke, and more

Mobility and Activity of Daily Living Outcomes After a Hip Fracture.

NCT07556263 · Hip Fractures (ICD-10 72.01-72.2)

Prehabilitation for Ovarian Cancer Patients

NCT05364879 · Prehabilitation, Exercise, and more

Feasibility of a Co-designed Mobility Intervention After Hip Fracture Surgery

NCT07561164 · Hip Fracture Surgery, Mobility Limitation, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 26, 2024Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment200

Start dateApr 2023

Last updatedSep 26, 2024

Condition

Frailty Hip Fracture Inflammatory Biomarkers

Locations shown

Larissa University Hospital

Larissa, Thessaly

UHL

Larissa, Thessaly

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 26, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions